|
2016 Journal Article Infection in cystic fibrosis: impact of the environment and climate (vol 10, pg 505, 2016)Ramsay, K. A., Stockwell, R. E. and Bell, S. C. (2016). Infection in cystic fibrosis: impact of the environment and climate (vol 10, pg 505, 2016). Expert Review of Respiratory Medicine, 10 (6), 713-713. doi: 10.1080/17476348.2016.1184473 |
|
2016 Journal Article JCF-2015Bell, Scott C., Hartl, Dominik and Flume, Patrick (2016). JCF-2015. Journal of Cystic Fibrosis, 15 (1). doi: 10.1016/S1569-1993(15)00319-7 |
|
2015 Journal Article Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic FibrosisTai, Anna Sze, Bell, Scott Cameron, Kidd, Timothy James, Trembizki, Ella, Buckley, Cameron, Ramsay, Kay Annette, David, Michael, Wainwright, Claire Elizabeth, Grimwood, Keith and Whiley, David Mark (2015). Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis. Plos One, 10 (12) e0144022, e0144022. doi: 10.1371/journal.pone.0144022 |
|
2015 Journal Article An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosisGeake, James B., Reid, David W., Currie, Bart J., Bell, Scott C., Bright-Thomas, Rowland, Dewar, Jane, Holden, Steve, Simmonds, Nicholas, Gyi, Khin, Kenna, Dervla, Waters, Valerie, Jackson, Mary, O'Sullivan, Brian, Taccetti, Giovanni, Kolbe, John, O'Carroll ,Mark, Campbell, Dee, Jaksic, Mirjana, Radhakrishna, Naghmeh, Kidd, Timothy J. and Flight, William (2015). An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis. BMC Pulmonary Medicine, 15 (1) 116. doi: 10.1186/s12890-015-0109-9 |
|
2015 Journal Article A new phase of CFTR treatment for cystic fibrosis?Bell, Scott C. (2015). A new phase of CFTR treatment for cystic fibrosis?. The Lancet Respiratory Medicine, 3 (9) 203, 662-663. doi: 10.1016/S2213-2600(15)00282-9 |
|
2015 Journal Article Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortiumFreschi, Luca, Jeukens, Julie, Kukavica-Ibrulj, Irene, Boyle, Brian, Dupont, Marie-Josee, Laroche, Jerome, Larose, Stephane, Maaroufi, Halim, Fothergill, Joanne L., Moore, Matthew, Winsor, Geoffrey L., Aaron, Shawn D., Barbeau, Jean, Bell, Scott C., Burns, Jane L., Camara, Miguel, Cantin, Andre, Charette, Steve J., Dewar, Ken, Deziel, Eric, Grimwood, Keith, Hancock, Robert E. W., Harrison, Joe J., Heebs, Stephan, Jelsbak, Lars, Jia, Baofeng, Kenna, Dervla T., Kidd, Timothy J., Klockgether, Jens ... Levesque, Roger C. (2015). Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium. Frontiers in Microbiology, 6 (SEP) 01036, 1-8. doi: 10.3389/fmicb.2015.01036 |
|
2015 Journal Article The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysisKidd, Timothy J., Magalhaes, Ricardo J. Soares, Paynter, Stuart and Bell, Scott C. (2015). The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis. The Lancet Respiratory Medicine, 3 (8), 640-650. doi: 10.1016/S2213-2600(15)00228-3 |
|
2015 Journal Article Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sourcesDe Smet, Birgit., Mayo, Mark., Peeters, Charlotte., Zlosnik, James E.A., Spilker, Theodore., Hird, Trevor J., Li Puma, John J., Kidd, Timothy J., Kaestli, Mirjam., Ginther, Jennifer L., Wagner, David M., Keim, Paul., Bell, Scott C., Jacobs, Jan A., Currie, Bart J. and Vandamme, Peter. (2015). Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sources. International Journal of Systematic and Evolutionary Microbiology, 65 (7), 2265-2271. doi: 10.1099/ijs.0.000251 |
|
2015 Journal Article Cystic fibrosisRatjen, Felix, Bell, Scott C., Rowe, Steven M., Goss, Christopher H., Quittner, Alexandra L. and Bush, Andrew (2015). Cystic fibrosis. Nature Reviews. Disease Primers, 1 (1) 15010 . doi: 10.1038/nrdp.2015.10 |
|
2015 Journal Article Idiosyncratic reactions are the most common cause of abnormal liver function tests in patients with cystic fibrosisJong, T., Geake, J., Yerkovich, S. and Bell, S. C. (2015). Idiosyncratic reactions are the most common cause of abnormal liver function tests in patients with cystic fibrosis. Internal Medicine Journal, 45 (4), 395-401. doi: 10.1111/imj.12707 |
|
2015 Journal Article Evaluation of phenotypic screening tests for carbapenemase production in Pseudomonas aeruginosa from patients with cystic fibrosisTai, Anna S., Sidjabat, Hanna E., Kidd, Timothy J., Whiley, David M., Paterson, David L. and Bell, Scott C. (2015). Evaluation of phenotypic screening tests for carbapenemase production in Pseudomonas aeruginosa from patients with cystic fibrosis. Journal of Microbiological Methods, 111, 105-107. doi: 10.1016/j.mimet.2015.02.006 |
|
2015 Journal Article Whole-genome sequences of five Burkholderia pseudomallei isolates from australian cystic fibrosis patientsViberg, Linda T., Price, Erin P., Kidd, Timothy J., Bell, Scott C., Currie, Bart J. and Sarovich, Derek S. (2015). Whole-genome sequences of five Burkholderia pseudomallei isolates from australian cystic fibrosis patients. Genome Announcements, 3 (2) e00254-15. doi: 10.1128/genomeA.00254-15 |
|
2015 Journal Article Molecular surveillance for carbapenemase genes in carbapenem-resistant Pseudomonas aeruginosa in Australian patients with cystic fibrosisTai, Anna S., Kidd, Timothy J., Whiley, David M., Ramsay, Kay A., Buckley, Cameron, Bell, Scott C., The ACPinCF Investigator Group and David, Michael (2015). Molecular surveillance for carbapenemase genes in carbapenem-resistant Pseudomonas aeruginosa in Australian patients with cystic fibrosis. Pathology, 47 (2), 156-160. doi: 10.1097/PAT.0000000000000216 |
|
2015 Journal Article Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New ZealandChang, Anne B., Bell, Scott C., Torzillo, Paul J., King, Paul T., Maguire, Graeme P., Byrnes, Catherine A., Holland, Anne E., O’Mara, Peter, Grimwood, Keith, Alison, Jenny, Cull, Chris, Currie, Bart, Gardner, Inge, Holmes, Peter, Hunter, Cameron, Kolbe, John, Maclennan, Carolyn, McDonald, Malcolm, Morris, Peter, Nicolson, Caroline, Petsky, Helen, Pillarisetti, Naveen, Reynolds, Emma, Serisier, David, Thein, Frank, van Asperen, Peter, Voss, Lesley and Wong, Conroy (2015). Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. Medical Journal of Australia, 202 (1), 21-24. doi: 10.5694/mja14.00287 |
|
2015 Journal Article Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-yearsKidd, Timothy J., Ramsay, Kay A., Vidmar, Suzanna, Carlin, John B., Bell, Scott C., Wainwright, Claire E. and Grimwood, Keith (2015). Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years. Journal of Cystic Fibrosis, 14 (3), 361-369. doi: 10.1016/j.jcf.2014.12.007 |
|
2015 Journal Article Future trends in cystic fibrosis demography in 34 European countriesBurgel, Pierre-Régis, Bellis, Gil, Olesen, Hanne V., Viviani, Laura, Zolin, Anna, Blasi, Francesco, Elborn, J. Stuart, Bell, Scott, Castellani, Carlo, Dembski, Birgit, Drevinek, Pavel, Heijerman, Harry, Innes, Alastair, Lindblad, Anders, Madge, Susan, De Rijcke, Karleen and Solé, Amparo (2015). Future trends in cystic fibrosis demography in 34 European countries. European Respiratory Journal, 46 (1), 133-141. doi: 10.1183/09031936.00196314 |
|
2015 Journal Article New pharmacological approaches for cystic fibrosis: Promises, progress, pitfallsBell, S.C., De Boeck, K. and Amaral, M.D. (2015). New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls. Pharmacology and Therapeutics, 145, 19-34. doi: 10.1016/j.pharmthera.2014.06.005 |
|
2015 Journal Article A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patientsStuart Elborn, J., Geller, David E., Conrad, Douglas, Aaron, Shawn D., Smyth, Alan R., Fischer, Rainald, Kerem, Eitan, Bell, Scott C., Loutit, Jeffery S., Dudley, Michael N., Morgan, Elizabeth E., VanDevanter, Donald R. and Flume, Patrick A. (2015). A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients. Journal of Cystic Fibrosis, 14 (4), 507-514. doi: 10.1016/j.jcf.2014.12.013 |
|
2015 Journal Article Non-invasive ventilation used as an adjunct to airway clearance treatments improves lung function during an acute exacerbation of cystic fibrosis: A randomised trialDwyer, Tiffany J., Robbins, Lisel, Kelly, Patrick, Piper, Amanda J., Bell, Scott C. and Bye, Peter T.P. (2015). Non-invasive ventilation used as an adjunct to airway clearance treatments improves lung function during an acute exacerbation of cystic fibrosis: A randomised trial. Journal of Physiotherapy, 61 (3), 142-147. doi: 10.1016/j.jphys.2015.05.019 |
|
2014 Journal Article JCF - 2014 and beyondBell, Scott C., Heijerman, Harry and Hartl, Dominik (2014). JCF - 2014 and beyond. Journal of Cystic Fibrosis, 13 (6), 610-611. doi: 10.1016/j.jcf.2014.09.009 |
